These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 28163005)
1. Letrozole not superior to anastrozole for early breast cancer. Brower V Lancet Oncol; 2017 Mar; 18(3):e138. PubMed ID: 28163005 [No Abstract] [Full Text] [Related]
2. Current developments in hormonal therapy of breast cancer. Buzdar AU Clin Breast Cancer; 2004 Sep; 5 Suppl 1():S4-5. PubMed ID: 15347432 [No Abstract] [Full Text] [Related]
3. Anastrozole may aid breast cancer prevention. Cancer Discov; 2014 Feb; 4(2):OF4. PubMed ID: 24501316 [TBL] [Abstract][Full Text] [Related]
4. Remission of macroglobulinemia during anastrozole treatment for breast cancer. Chettle C; Baker MA N Engl J Med; 2005 Apr; 352(16):1725-6. PubMed ID: 15843681 [No Abstract] [Full Text] [Related]
5. Letrozole compared with tamoxifen as initial adjuvant therapy for breast cancer. Buzdar AU J Clin Oncol; 2007 May; 25(15):2147-8; author reply 2148. PubMed ID: 17513830 [No Abstract] [Full Text] [Related]
6. The bone substudy of MA.27: does bone make a difference? Mathew A; Brufsky A Lancet Oncol; 2014 Apr; 15(4):375-7. PubMed ID: 24636209 [No Abstract] [Full Text] [Related]
7. Adjuvant aromatase inhibitors for breast cancer. Howell A Lancet; 2005 Aug 6-12; 366(9484):431-3. PubMed ID: 16084234 [No Abstract] [Full Text] [Related]
8. Aromatase inhibitors come of age. Dowsett M Ann Oncol; 1997 Jul; 8(7):631-2. PubMed ID: 9296213 [No Abstract] [Full Text] [Related]
9. Prevention: targeted therapy-anastrozole prevents breast cancer. Brown P Nat Rev Clin Oncol; 2014 Mar; 11(3):127-8. PubMed ID: 24535168 [No Abstract] [Full Text] [Related]
10. Anastrozole (Arimidex), a new aromatase inhibitor for advanced breast cancer: mechanism of action and role in management. Hortobagyi GN; Buzdar AU Cancer Invest; 1998; 16(6):385-90. PubMed ID: 9679529 [No Abstract] [Full Text] [Related]
11. The Breast International Group 1-98 trial: big results for women with hormone-sensitive early breast cancer. Monnier AM Expert Rev Anticancer Ther; 2007 May; 7(5):627-34. PubMed ID: 17492927 [TBL] [Abstract][Full Text] [Related]
12. A case of brain metastases from breast cancer that responded to anastrozole monotherapy. Ito K; Ito T; Okada T; Watanabe T; Gomi K; Kanai T; Mochizuki Y; Amano J Breast J; 2009; 15(4):435-7. PubMed ID: 19470131 [No Abstract] [Full Text] [Related]
13. NICE urged to recommend anastrozole for breast cancer prevention. Wise J BMJ; 2013 Dec; 347():f7458. PubMed ID: 24336098 [No Abstract] [Full Text] [Related]
14. Adjuvant aromatase inhibitor therapy for early breast cancer: A review of the most recent data. Grana G J Surg Oncol; 2006 Jun; 93(7):585-92. PubMed ID: 16705732 [TBL] [Abstract][Full Text] [Related]
15. An open randomised trial of second-line endocrine therapy in advanced breast cancer: comparison of the Aromatase inhibitors letrozole and anastrozole. Tobias JS; Howell A Eur J Cancer; 2004 Aug; 40(12):1913. PubMed ID: 15288295 [No Abstract] [Full Text] [Related]
16. Anastrozole for breast cancer: recent advances and ongoing challenges. Buzdar AU Expert Rev Anticancer Ther; 2006 Jun; 6(6):839-48. PubMed ID: 16761927 [TBL] [Abstract][Full Text] [Related]
17. ERBB2 status and outcome of endocrine treatment. Miller WR Lancet Oncol; 2008 Jan; 9(1):4-5. PubMed ID: 18177812 [No Abstract] [Full Text] [Related]